Researchers have developed a new blood test that can identify cancer in the body as part of a National Health Service (NHS) ...

A blood test looking for five specific proteins can predict metabolic dysfunction-associated steatotic liver disease (MASLD), ...

Scientists have identified five specific blood proteins that can accurately predict a person's risk for developing a serious form of liver disease as early as 16 years before they experience symptoms, ...

Early identification of individuals at a high risk for MASLD could “profoundly transform” intervention strategies, experts say.

The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

A number of the Dutch firm's products have received certification under Europe's In Vitro Diagnostic Regulation recently.